Yingying Huang

A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma

Wu‐tong Ju, Ronghui Xia, Dongwang Zhu et al. · Nature Communications · 2022 · 121 citations · Full text

Medicine, Oncology, Pharmacology +17

SIRT1 reverses senescence via enhancing autophagy and attenuates oxidative stress-induced apoptosis through promoting p53 degradation

Tao Liu, Xiaorong Ma, Tianxiang Ouyang et al. · International Journal of Biological Macromolecules · 2018 · 92 citations

Life Sciences, Cell Biology, Molecular Biology +14

Collagen I Induces Preeclampsia-Like Symptoms by Suppressing Proliferation and Invasion of Trophoblasts

Yinglin Feng, Xia Chen, Huiqiao Wang et al. · Frontiers in Endocrinology · 2021 · 37 citations · Full text

Medicine, Obstetrics, Pathology +17

Prevalence of <i>PRKDC</i> mutations and association with response to immune checkpoint inhibitors in solid tumors

Yu Chen, Yi Li, Yanfang Guan et al. · Molecular Oncology · 2020 · 34 citations · Full text

Medicine, Cancer Biology, Oncology +17

Metabolic tumor volume and conformal radiotherapy based on prognostic PET/CT for treatment of nasopharyngeal carcinoma

Zhaodong Fei, Chuanben Chen, Yingying Huang et al. · Medicine · 2019 · 28 citations · Full text

Medicine, Nuclear Medicine, Oncology +17